Russia launches 2nd phase of MIR-19 COVID medication trials

In a bid to beat coronavirus, the second phase of clinical trials is taking place in Russia of its MIR-19 – a new medication specifically developed for treating COVID, which is expected to be registered next month. Follow us on Telegram /